KR900700093A - 수용성 이부프로펜 제제 및 그 제조방법 - Google Patents

수용성 이부프로펜 제제 및 그 제조방법

Info

Publication number
KR900700093A
KR900700093A KR1019890702189A KR890702189A KR900700093A KR 900700093 A KR900700093 A KR 900700093A KR 1019890702189 A KR1019890702189 A KR 1019890702189A KR 890702189 A KR890702189 A KR 890702189A KR 900700093 A KR900700093 A KR 900700093A
Authority
KR
South Korea
Prior art keywords
ibuprofen
alkali metal
aqueous solvent
formulation
moles
Prior art date
Application number
KR1019890702189A
Other languages
English (en)
Inventor
로날드 티. 하스
Original Assignee
원본미기재
오라테크 파마슈티칼 디벨롭먼트 코오포레이숀
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 오라테크 파마슈티칼 디벨롭먼트 코오포레이숀 filed Critical 원본미기재
Publication of KR900700093A publication Critical patent/KR900700093A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

내용 없음

Description

수용성 이부프로펜 제제 및 그 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (11)

  1. 이부프로펜의 알카리금속염을 함유하는 물질의 고체결정질 제제.
  2. 제1항에 있어서, 상기 이부프로펜의 알카리금속염이 이부프로펜의 칼륨염인 제제.
  3. 제1항에 있어서, 상기 이부프로펜의 알카리금속염이 이부프로펜의 나트륨염인 제제.
  4. 소정량의 알카리금속중탄산염을 수성용매에 용해시키는 단계, 및 소정량의 이부프로펜 제제를 수성용매에 용해시키는 단계로 구성되는 이부프로펜의 알카리금속염의 제조방법.
  5. 제4항에 있어서, 상기 수성용매로부터 고체알카리금속 이부프로펜을 추출하는 단계를 부가로 포함하는 방법.
  6. 제4항에 있어서, 상기 알카리금속 중탄산염이 중탄산칼륨으로 구성되고 상기 이부프로펜의 알카리금속염이 이부프로펜의 칼륨염으로 구성되는 방법.
  7. 제4항에 있어서, 상기 알카리금속 중탄산염이 중탄산나트륨으로 구성되고 상기 이부프로펜의 알카리금속염의 이부프로펜의 나트륨염으로 구성되는 방법.
  8. 제4항에 있어서, 소정량의 알카리금속 중탄산염을 수성용매에 용해시키는 단계가 소정몰수의 알카리금속 중탄산염을 수성용매에 용해시키는 단계로 구성되고, 소정량의 이부프로펜 제제를 수성용매에 용해시키는 단계가 소정몰수의 이부프로펜제제를 수성용매에 용해시키는 단계로 구성되며, 상기 알카리금속 중탄산염의 소정몰수가 적어도 이부프로펜제제의 소정몰수만큼 큰 방법.
  9. 제8항에 있어서, 상기 이부프로펜 제제가 이부프로펜의 알카리금속염으로 완전하고 효율적으로 전환될 수 있도록 상기 알카리 금속중탄산염의 소정몰수가 이부프로펜제제의 소정몰수보다 큰 방법.
  10. 경구투여시에 이부프로펜의 향이 없고 감소된 소성감을 가지는 액체 이부프로펜제제에 있어서, 수성용매에 용해된 소정량의 알카리금속 중탄산제제, 및 수성용매에 용해된 소정량의 이부프로펜 제제로 구성되고, 상기 수성용매에 용해된 알카리금속 중탄산염의 몰수가 적어도 상기 수성용매에 용해된 이부프로펜제제의 몰수만큼 큰 제제.
  11. 제10항에 있어서, 상기 수성용매에 용해된 알카리금속중탄산염제제의 몰수와 상기 수성용매에 용해된 이부프로펜 제제의 몰수와의 비가 상기 액체조성물을 경구투여할 때 이부프로펜의 향이 거의 제거되고 소성감이 거의 감소되는 정도인 제제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890702189A 1988-03-25 1989-03-23 수용성 이부프로펜 제제 및 그 제조방법 KR900700093A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/173,299 US4859704A (en) 1987-10-15 1988-03-25 Water soluble ibuprofen compositions and methods of making them
US173,299 1988-03-25
PCT/US1989/001203 WO1989009053A1 (en) 1988-03-25 1989-03-23 Water soluble ibuprofen compositions and methods of making them

Publications (1)

Publication Number Publication Date
KR900700093A true KR900700093A (ko) 1990-08-11

Family

ID=22631385

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890702189A KR900700093A (ko) 1988-03-25 1989-03-23 수용성 이부프로펜 제제 및 그 제조방법

Country Status (7)

Country Link
US (1) US4859704A (ko)
EP (1) EP0406307A4 (ko)
JP (1) JPH03502800A (ko)
KR (1) KR900700093A (ko)
AU (1) AU3359389A (ko)
IL (1) IL89702A0 (ko)
WO (1) WO1989009053A1 (ko)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262179A (en) * 1989-09-13 1993-11-16 Nicholas Kiwi Pty Ltd. Non-effervescent ibuprofen compositions
GEP20002013B (en) * 1991-05-13 2000-04-10 Boots Co Plc Therapeutical Means
DE4140172C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Ibuprofen enthaltendes Arzneimittel
DE4140183C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Retardform für ein Flurbiprofen enthaltendes Arzneimittel
DE4140185C2 (de) * 1991-12-05 1996-02-01 Alfatec Pharma Gmbh Ein 2-Arylpropionsäurederivat in Nanosolform enthaltendes Arzneimittel und seine Herstellung
DE4140184C2 (de) * 1991-12-05 1995-12-21 Alfatec Pharma Gmbh Akutform für ein Flurbiprofen enthaltendes Arzneimittel
US6348216B1 (en) 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
US5712310A (en) * 1996-06-14 1998-01-27 Alpharma Uspd, Inc. Suspension of substantially water-insoluble drugs and methods of their manufacture
US6465009B1 (en) * 1998-03-18 2002-10-15 Yamanouchi Pharmaceutical Co., Ltd. Water soluble polymer-based rapidly dissolving tablets and production processes thereof
ES2288872T3 (es) * 1999-09-29 2008-02-01 R.P. Scherer Technologies, Inc. Granulaciones con celulosa hidrolizada de sales de medicamentos.
US20040132823A1 (en) * 2001-11-02 2004-07-08 Leo Pavliv Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
US20030232097A1 (en) * 2002-06-17 2003-12-18 Strides Inc. Oily wax matrix suspension formulation comprising ibuprofen free acid and potassium salt of ibuprofen
US7090859B2 (en) * 2002-12-13 2006-08-15 Ronald Thomas Haas Ketoprofen compositions and methods of making them
US20050137262A1 (en) * 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
EP1800667A1 (en) 2005-12-23 2007-06-27 Losan Pharma GmbH Rapidly solubilizing ibuprofen granulate
ES2546258T3 (es) 2005-03-22 2015-09-22 Stada Arzneimittel Ag Ibuprofeno solubilizado
WO2007035448A2 (en) * 2005-09-19 2007-03-29 Albemarle Corporation Highly concentrated pourable aqueous solutions of potassium ibuprofen their preparation and their uses
US20070265344A1 (en) * 2006-02-06 2007-11-15 Pharmaceutical Solutions, Inc. Non-steroidal anti-inflammatory oral powder and liquid preparations for administration to animals
CL2007002425A1 (es) * 2006-08-22 2008-06-27 Albermarle Corp Procedimiento de preparacion controlado de sal sodica de ibuprofeno de tamano de particula mediano; y dichas particulas de sal sodica.
JP2011510005A (ja) * 2008-01-18 2011-03-31 ダウ グローバル テクノロジーズ インコーポレイティド メトキシポリエチレングリコールを用いる難溶性活性物質の水溶解度増強方法
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
WO2010011522A1 (en) 2008-07-21 2010-01-28 Albemarle Corporation High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
WO2011001228A1 (en) * 2008-08-14 2011-01-06 Shasun Chemicals And Drugs Limited Aryl alkyl carboxylic acid salts, process for preparation and dosage forms
BRPI0918142A2 (pt) 2008-09-10 2015-12-01 Biochemics Inc composição farmaclógica tópica, seu método de preparação, bem como uso da forma de ácido livre de ácido 2-(4-isobutifilfenil)prpiônico
WO2010034019A1 (en) 2008-09-22 2010-03-25 Biochemics, Inc. Transdermal drug delivery using an osmolyte and vasoactive agent
KR20140014350A (ko) 2009-03-12 2014-02-06 큠버랜드 파마슈티컬즈 인코포레이티드 정맥 내 투여용 이부프로펜의 투여
US8735452B2 (en) * 2009-07-15 2014-05-27 Cumberland Pharmaceuticals Inc. Treating patients with intravenous ibuprofen
US8871810B2 (en) * 2009-07-15 2014-10-28 Cumberland Pharmaceuticals Inc. Treating critically ill patients with intravenous ibuprofen
WO2011014208A1 (en) * 2009-07-31 2011-02-03 Leo Pavliv Treating critically ill patients with intravenous ibuprofen
US9072710B2 (en) 2012-03-16 2015-07-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
CA2867477C (en) 2012-03-16 2017-09-26 Cumberland Pharmaceuticals, Inc. Injectable ibuprofen formulation
US9072661B2 (en) 2012-03-16 2015-07-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
US10561627B2 (en) * 2014-12-31 2020-02-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermetic surfactant films

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB867803A (en) * 1958-08-26 1961-05-10 R J Strasenburgh Co Improvements in or relating to thixotropic pharmaceutical compositions and their manufacture
US3041239A (en) * 1959-05-28 1962-06-26 Johnson & Johnson Stable aqueous salicylamide composition and method of preparing same
GB971700A (en) * 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents
CH524372A (de) * 1969-01-29 1972-06-30 Ciba Geigy Ag Verfahren zur Herstellung von stabilen Elixieren, welche therapeutisch verwendbare tricyclische basische Wirkstoffe in Form ihrer Mononatriumpamoate enthalten
JPS5537528B2 (ko) * 1972-12-11 1980-09-29
JPS5831210B2 (ja) * 1973-04-09 1983-07-05 武田薬品工業株式会社 アンテイナスイセイケンダクエキノセイゾウホウ
US3903297A (en) * 1973-11-01 1975-09-02 Upjohn Co Method of treatment and prophylaxis of gastric hypersecretion and gastric and duodenal ulcers using prostaglandin analogs
US4031243A (en) * 1975-07-03 1977-06-21 Juste, S.A. Quimico-Farmaceutica 2-(4-Isobutyl phenyl)butyric acid, salts thereof, and pharmaceutical compositions containing the same
US4145440A (en) * 1977-08-18 1979-03-20 The Upjohn Company Liquid suspension of an aluminum salt of ibuprofen
US4344929A (en) * 1980-04-25 1982-08-17 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4282252A (en) * 1980-05-15 1981-08-04 Thomas Jefferson University Method of increasing coronary blood flow with ibuprofen
US4361580A (en) * 1980-06-20 1982-11-30 The Upjohn Manufacturing Company Aluminum ibuprofen pharmaceutical suspensions
US4346108A (en) * 1981-06-22 1982-08-24 The Upjohn Manufacturing Company M Method for preventing adhesion formation
JPS584720A (ja) * 1981-06-26 1983-01-11 ザ・アツプジヨン・カンパニ− 鎮痛用医薬組成物
DE3270988D1 (en) * 1981-07-20 1986-06-12 Upjohn Co Use of ibuprofen or flurbiprofen for the manufacture of a medicament for treating respiratory disorders
US4447451A (en) * 1981-07-20 1984-05-08 The Upjohn Manufacturing Company M Treatment of adult respiratory distress syndrome
JPS5829706A (ja) * 1981-08-14 1983-02-22 Toko Yakuhin Kogyo Kk 消炎鎮痛外用剤
IT1198351B (it) * 1981-09-21 1988-12-21 Montedison Spa Processo per la carbonilazione di alogenuri benzilici secondari
IT1139455B (it) * 1981-09-21 1986-09-24 Montedison Spa Processo per la preparazione di acidi alfa-arilpropionici e loro sali alcalini
US4713249A (en) * 1981-11-12 1987-12-15 Schroeder Ulf Crystallized carbohydrate matrix for biologically active substances, a process of preparing said matrix, and the use thereof
DE3205504C2 (de) * 1982-02-16 1983-12-01 Dolorgiet Gmbh & Co Kg, 5300 Bonn Äußerlich anwendbares, Ibuprofen enthaltendes Arzneimittel
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4404210A (en) * 1982-06-30 1983-09-13 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and ibuprofen
US4447443A (en) * 1982-11-15 1984-05-08 Merck & Co., Inc. Anti-inflammatory/analgesic combination of α-fluoromethylhistidine and a selected non-steroidal anti-inflammatory drug (NSAID)
US4599359A (en) * 1982-12-09 1986-07-08 Stephen A. Cooper Hydroxyzine-containing analgesic combinations
US4439450A (en) * 1983-06-30 1984-03-27 The Upjohn Manufacturing Company M Treatment of the blood-brain barrier with ibuprofen
JPH0647532B2 (ja) * 1983-08-31 1994-06-22 ジ アツプジヨン カンパニ− 歯槽骨吸収の治療
US4558051A (en) * 1983-10-11 1985-12-10 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4717713A (en) * 1983-10-31 1988-01-05 Research Corporation Controlled release liquid pharmaceutical
US4681897A (en) * 1984-01-16 1987-07-21 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4609675A (en) * 1984-08-17 1986-09-02 The Upjohn Company Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
DE3437599C2 (de) * 1984-10-13 1987-04-16 Dolorgiet GmbH & Co KG, 5205 St Augustin Ibuprofen enthaltende Weichgelatinekapseln
US4587252A (en) * 1984-12-18 1986-05-06 Brighton Pharmaceutical, Inc. Hydrocodone/ibuprofen pharmaceutical compositions and method
US4571400A (en) * 1984-12-18 1986-02-18 Belleview Pharmaceutical, Inc. Dihydrocodeine/ibuprofen pharmaceutical compositions and method
US4569937A (en) * 1985-02-11 1986-02-11 E. I. Du Pont De Nemours And Company Analgesic mixture of oxycodone and ibuprofen
US4695591A (en) * 1985-03-29 1987-09-22 Schering Corporation Controlled release dosage forms comprising hydroxypropylmethylcellulose
US4687662A (en) * 1985-08-30 1987-08-18 Warner-Lambert Company Therapeutic effervescent composition
IT1209667B (it) * 1985-11-12 1989-08-30 Zambon Spa Composizione effeverscente adattivita' analgesica.
GB8528195D0 (en) * 1985-11-15 1985-12-18 Boots Co Plc Therapeutic compositions
JPS62126122A (ja) * 1985-11-27 1987-06-08 Showa Shinyaku Kk 表面コ−テイングされたイブプロフエン顆粒の製法
US4684666A (en) * 1986-08-19 1987-08-04 Haas Pharmaceuticals, Inc. Stabilized liquid analgesic compositions
US4788220A (en) * 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
US4861797A (en) * 1987-10-15 1989-08-29 Oratech Pharmaceutical Development Corporation Liquid ibuprofen compositions and methods of making them

Also Published As

Publication number Publication date
AU3359389A (en) 1989-10-16
EP0406307A1 (en) 1991-01-09
EP0406307A4 (en) 1991-03-20
JPH03502800A (ja) 1991-06-27
US4859704A (en) 1989-08-22
WO1989009053A1 (en) 1989-10-05
IL89702A0 (en) 1989-09-28

Similar Documents

Publication Publication Date Title
KR900700093A (ko) 수용성 이부프로펜 제제 및 그 제조방법
EP0244178A3 (en) Intraocular dosage compositions and method of use
KR880001295A (ko) 약학조성물
IE40361L (en) Bismuth containing pharmaceutical compositions
KR890015745A (ko) 수용액으로 존재하는 피록시캄의 제약 조성물 및 그의 제조방법
KR930001887A (ko) 치과용 석고 조성물
ES2032681T3 (es) Una composicion farmaceutica anti-inflamatoria, con eliminacion, en solucion, de sabor amargo, ardor de la garganta y toxicidad intestinal. (reserva del art. 167.2 cpe).
KR910007509A (ko) 친유성 약제용 주사 조성물
ES370058A1 (es) Procedimiento para la preparacion de composiciones farma- ceuticas efervescentes.
KR880009654A (ko) 아세트알데히드의 독성을 감소시키는 조성물 및 방법
GB1483840A (en) Pharmaceutical preparation containing acetylsalicylic aci
ES2174388T3 (es) Solucion liquida de medicamento para administracion oral.
KR930012018A (ko) 약제학적 조성물
KR850006136A (ko) 에토포사이드 경구 투여형태
KR850004252A (ko) 히드록시 알킬카르복실 메틸화 타마린드호제(糊劑)
JPS5492618A (en) Poultice
JPS5350245A (en) Compsition giving mildew-resisting and viscosity reduction-preventingproperties to aqueous high polymer
JPS57158719A (en) Rectal administration pharmaceutical
KR860000070A (ko) 종양 발육억제 조성물
KR890012960A (ko) 결정성 β-락탐 용매화물
JPS52117413A (en) Protective coating composition using aqueous solvent
JPS5344509A (en) Preparation of powdery glyoxal
KR920703501A (ko) 세바스산 및 그 유도체의 장 경우 영양 및 비경구적 영양에서의 용도 및 이들 화합물을 함유한 의약 조성물
JPS56139414A (en) Stabilizing method of aqueous solution
KR880012518A (ko) 나프탈-아세트산 유도체를 함유하는 진통 및 소염제약 조성물

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid